% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Gambichler:283178,
author = {T. Gambichler and N. Schuleit and L. Susok and J.
Becker$^*$ and C. H. Scheel and C. Torres-Reyes and O.
Overheu and A. Reinacher-Schick and W. Schmidt},
title = {{P}rognostic {P}erformance of {I}nflammatory {B}iomarkers
{B}ased on {C}omplete {B}lood {C}ounts in {COVID}-19
{P}atients.},
journal = {Viruses},
volume = {15},
number = {9},
issn = {1999-4915},
address = {Basel},
publisher = {MDPI},
reportid = {DKFZ-2023-01957},
pages = {1920},
year = {2023},
abstract = {With the end of the pandemic, COVID-19 has entered an
endemic phase with expected seasonal spikes. Consequently,
the implementation of easily accessible prognostic
biomarkers for patients with COVID-19 remains an important
area of research. In this monocentric study at a German
tertiary care hospital, we determined the prognostic
performance of different clinical and blood-based parameters
in 412 COVID-19 patients. We evaluated the
neutrophil-to-lymphocyte ratio (NLR), systemic
immune-inflammation index (SII), pan-immune-inflammation
value (PIV), and absolute eosinopenia (AEP, 0/µL) of
COVID-19 patients (n = 412). The Siddiqui and Mehra staging
proposal, the WHO clinical progression scale, and
COVID-19-associated death were used as COVID-19 outcome
measures. With respect to Siddiqi and Mehra staging, patient
age of older than 75 years, high C-reactive protein (CRP),
absolute eosinopenia (AEP), cardiovascular comorbidities,
and high ferritin were significant independent predictors
for severe COVID-19. When outcome was determined according
to the WHO clinical progression scale, patient age of older
than 75 years, high CRP, high LDH, AEP, high
neutrophil-to-lymphocyte ratio (NLR), and the presence of
pulmonal comorbidities were significant independent
predictors for severe COVID-19. Finally, COVID-19-associated
death was predicted independently by patient age of older
than 75 years, high LDH, high NLR, and AEP. Eosinopenia (<
40/µL) was observed in $74.5\%$ of patients, and AEP in
almost $45\%.$ In conclusion, the present real-world data
indicate that the NLR is superior to more complex systemic
immune-inflammation biomarkers (e.g., SII and PIV) in
COVID-19 prognostication. A decreased eosinophil count
emerged as a potential hallmark of COVID-19 infection,
whereas AEP turned out to be an accessible independent
biomarker for COVID-19 severity and mortality.},
keywords = {C-reactive protein (Other) / SARS-CoV-2 (Other) /
comorbidities (Other) / eosinopenia (Other) / eosinophils
(Other) / ferritin (Other) / lactate dehydrogenase (Other) /
systemic immune-inflammation (Other)},
cin = {ED01},
ddc = {050},
cid = {I:(DE-He78)ED01-20160331},
pnm = {899 - ohne Topic (POF4-899)},
pid = {G:(DE-HGF)POF4-899},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:37766326},
doi = {10.3390/v15091920},
url = {https://inrepo02.dkfz.de/record/283178},
}